Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder: Current Status of Knowledge

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.7, 2011-07, pp. : 539-554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Limited data suggest that the long-term use of stimulants in children with attention-deficit hyperactivity disorder is effective and safe

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 20, Iss. 11, 2004-11 ,pp. : 14-16

Adis International

Access to resources Recommend Favorite

Medication Costs to Private Insurers of Diversion of Medications for Attention-Deficit Hyperactivity Disorder

By Aldridge Arnie P.

PharmacoEconomics, Vol. 29, Iss. 7, 2011-07 ,pp. : 621-635

Adis International

Access to resources Recommend Favorite

The Impact of Medications on Quality of Life in Attention-Deficit Hyperactivity Disorder: A Systematic Review

By Coghill David

CNS Drugs, Vol. 24, Iss. 10, 2010-10 ,pp. : 843-866

Adis International

Access to resources Recommend Favorite

Long-Term Stimulant Effects in Children with Attention Deficit Hyperactivity Disorder (ADHD)

Child and Adolescent Psychopharmacology News, Vol. 9, Iss. 1, 2004-02 ,pp. : 1-12

Guilford Publications Inc

Access to resources Recommend Favorite

Long-Term Use of Stimulants in Children with Attention Deficit Hyperactivity Disorder: Safety, Efficacy, and Long-Term Outcome

By Hechtman L. Greenfield B.

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 787-794

Adis International

Access to resources Recommend Favorite